The RECONCILE study protocol: Exploiting image-based risk stratification in early prostate cancer to discriminate progressors from non-progressors (RECONCILE)
We have designed and implemented a prospective, longitudinal study to evaluate the underlying molecular landscape of intermediate risk, MR-visible prostate tumours. Recruitment is ongoing.
Authors
- Gerhardt Attard (ORCID: https://orcid.org/0000-0002-4811-7983)
- Caroline M. Moore (ORCID: https://orcid.org/0000-0003-0202-7912)
- Anna Wingate (ORCID: https://orcid.org/0009-0008-4965-7093)
- Teresa Marsden (ORCID: https://orcid.org/0000-0002-1800-3547)
- Clément Orczyk (ORCID: https://orcid.org/0000-0003-3067-2409)
- Alex Freeman (ORCID: https://orcid.org/0000-0001-5031-3791)
- Shonit Punwani (ORCID: https://orcid.org/0000-0002-1014-0870)
- Norman Williams (ORCID: https://orcid.org/0000-0001-6496-312X)
- Aiman Haider (ORCID: https://orcid.org/0000-0002-7005-4245)
- Tom Syer (ORCID: https://orcid.org/0000-0001-9594-9638)
- Mark Emberton (ORCID: https://orcid.org/0000-0003-4230-0338)
- Nora Pashayan
- Francesco Giganti
Institutions
- University College London Hospitals NHS Foundation Trust (GB)
- University College London (GB)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1371/journal.pone.0295994
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Movember Foundation
- Cancer Research UK
- National Institute for Health and Care Research
- Prostate Cancer UK
- European Commission
- Astellas Pharma
- University College London Hospitals NHS Foundation Trust
- Medical Research Council
- UCLH Biomedical Research Centre